Adjuvant therapy of primary breast cancer. 4th International Conference on Adjuvant Therapy of Primary Breast Cancer St. Gallen, Switzerland.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Annals of Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/oxfordjournals.annonc.a058099PMID 1286043
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years.

  1989cited by this paper
• Meeting highlights: adjuvant therapy for breast cancer.

  1988cited by this paper

• Tumor Site and Breast Cancer Prognosis

  2018cites this paper
• Factors associated with receipt of adjuvant chemotherapy among married women with breast cancer

  2013cites this paper
• Age, comorbidity, and breast cancer severity: impact on receipt of definitive local therapy and rate of recurrence among older women with early-stage breast cancer.

  2011cites this paper
• Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: can radiotherapy ever be safely withheld?

  2009cites this paper
• Referral, receipt, and completion of chemotherapy in patients with early-stage breast cancer older than 65 years and at high risk of breast cancer recurrence.

  2009cites this paper
• Association of DNA-PK activity and radiation-induced NBS1 foci formation in lymphocytes with clinical malignancy in breast cancer patients.

  2007cites this paper
• Long‐term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection

  2006cites this paper
• Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93)--the German Adjuvant Breast Cancer Group.

  2005cites this paper
• Predictors and outcomes of surgeons' referral of older breast cancer patients to medical oncologists

  2005cites this paper
• Quality of adjuvant CMF chemotherapy for node-positive primary breast cancer: a population-based study

  2004cites this paper
• Epirubicin-cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 study.

  2004cites this paper
• Ethical issues surrounding the conduct of off-shore clinical research.

  2002cites this paper
• Relationship between tumor location and relapse in 6,781 women with early invasive breast cancer.

  2000cites this paper
• Breast cancer practice patterns at VA hospitals: implications for future research.

  1998cites this paper
• Comparison of estrogen receptor determinations by a biochemical ligand‐binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials

  1996cites this paper
• Meeting highlights: international consensus panel on the treatment of primary breast cancer.

  1995cites this paper
• Principles of adjuvant therapy.

  1995cites this paper
• Fifth International Conference on Adjuvant Therapy of Breast Cancer, St Gallen, March 1995. International Consensus Panel on the Treatment of Primary Breast Cancer.

  1995cites this paper
• How does the message of cancer specialists affect routine medical practice? Only sixty percent of surgical adjuvant breast cancer treatment is based on hormone receptor status.

  1994cites this paper
• A practical view of prognostic factors for staging, adjuvant treatment planning, and as baseline studies for possible future therapy.

  1994cites this paper
• Adjuvant therapy for breast cancer.

  1994cites this paper
• Tamoxifen: a review of pharmacoeconomic and quality-of-life considerations for its use as adjuvant therapy in women with breast cancer.

  1993cites this paper
• Proliferation, basement membrane changes, metastasis and vascularization patterns in human breast cancer.

  1993cites this paper
• [Adjuvant chemo- and hormone therapy of breast cancer].

  1993cites this paper